Cellectis
CLLS
45 hedge funds and large institutions have $30.6M invested in Cellectis in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.16% less ownership
Funds ownership: 26.98% → 23.82% (-3.2%)
12% less funds holding
Funds holding: 51 → 45 (-6)
42% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 19
44% less capital invested
Capital invested by funds: $54.7M → $30.6M (-$24.1M)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
90% less call options, than puts
Call options by funds: $3K | Put options by funds: $29K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$878K |
| 2 |
State Street
Boston,
Massachusetts
|
+$472K |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$470K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$224K |
| 5 |
Millennium Management
New York
|
+$176K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$3.56M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$1.31M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$708K |
| 4 |
Two Sigma Investments
New York
|
-$599K |
| 5 |
Jane Street
New York
|
-$398K |
CLLS Hedge Fund Activity: Q2 2022 in Review
45 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2022, worth a combined $30.6M — down 44% from $54.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CLLS and 5 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 11 added.
The largest buyer was Long Focus Capital Management, adding an estimated $878K. The largest seller was Capital International Investors, cutting an estimated $3.56M.
- 45 institutional investors held Cellectis (CLLS) as of Q2 2022, down from 51 in Q1 2022.
- Funds reported $30.6M of Cellectis stock for Q2 2022, down 44% quarter-over-quarter.
- 5 funds opened new Cellectis positions in Q2 2022 and 11 closed out, a net change of -6 holders.
- The largest Cellectis buyer in Q2 2022 was Long Focus Capital Management, an estimated $878K added.
- The largest Cellectis seller in Q2 2022 was Capital International Investors, an estimated $3.56M sold.
Based on aggregated 13F filings for Q2 2022.